Nagi Bioscience, a Swiss life sciences company developing next-generation laboratory equipment to unlock the full potential of alternatives to animal…

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, announces the launch…

The Biopôle-based start-up has developed its machine learning platform dedicated to materials discovery. The seed-round was round led by AgFunder and…

This great Swiss Health Valley🇨🇭 initiative was started by CSS and EPFL Innovation Park to promote Medicine 3.0. The 9…

Future Health Lausanne is taking place on 3 October 2023 at the Swisstech Convention Center in Lausanne. The event is…

Adiposs SA, a Swiss biotech company developing medical imaging products and technologies, announced the completion of the phase I clinical…

The Geneva-based pharmaceutical company will use the grant to support its programme for mild neurocognitive disorders (mNCD).     The…

Geneva-based deeptech startup Multiwave Technologies SA, led by Tryfon and Panos Antonakakis, is attracting new capital that will be dedicated…

A team of Swiss researchers has discovered a way of prolonging the efficacy of CAR-T cells in immunotherapy for the…

Over the decades, Mecaplast Swiss has extended its offering beyond plastic injection per-say. The company may collaborate as early as the design phase, up to shipping fully finished products to its clients across the globe. The new ISO 7 clean room strengthens the offer as it is mainly be dedicated to the post-injection operations, assembly, finishing and packaging to meet the fast-growing demand of the MedTech industry.

Production of the Moderna serum will cease at Visp in the canton of Valais. In addition, Lonza’s Managing Director, Pierre-Alain…

The story begins in 1963, in Canton of Vaud (Switzerland) with the know-how gathering of small companies active in manufacturing…

CUTISS AG, a Swiss company specialising in regenerative skin medicine and tissue engineering, has announced the launch of its Series…

Les Grands Prix de l’économie 2023 are organised by the CCIG, with the support of the State of Geneva and…

The two major families of cells that make up the brain, neurons and glial cells, secretly hid a hybrid cell,…

The 13th edition of the TOP 100 Swiss Startup Award celebrated Switzerland’s best startups according to a 100-person strong jury:…

Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, announces the granting of a significant patent…

Healthcare Konnect (HCK) and Coreline Europe GmbH start a new partnership to amplify the inherent value of diagnostic accuracy.  …

Two Western Switzerland startups join forces to revolutionize medical imaging   Agora Care is a Geneva-based company developing a patient-centered…

A team from UNIGE has identified a new process governing the growth of the ‘roads’ that enable cells to thrive….

ten23 health®, a global contract development and manufacturing organization, announced a capacity expansion for the manufacture of sterile drug product…

The Geneva-based biotech startup won Venture Kick’s second stage of financial and entrepreneurial support. The project aims to achieve optimal…

The Swiss start-up created a stretchable high-channel electrode grid that was successfully used in a first-in-human clinical study in a…

Nearly 1,800 people have already used the CHUV@home application since it was launched in 2021. Patients who have undergone surgery…

The Pôle Santé Campus in Valais will bring together on the same site training activities in health and social work,…

In the heart of the Swiss Health Valley, the holding company AEVIS VICTORIA SA is investing more than CHF 100…

A team from the University and the HUG has determined which imaging technique is best for early detection of the…

10 medtech projects were selected to join the Swiss National Startup team that will travel to Boston and Cambridge next…

The start-up develops sensors and algorithms to provide a real-time assessment of the risk of concussion for professional athletes.  …

PhenomX Health SA, a femtech start–up based in Biopôle, launches a wellness and precision nutrition app for menopause care in Switzerland,…

Tissues, blood vessels, cells: tumours develop in a complex ecosystem known as the tumour microenvironment.  A team from the University…

The Bern-based start-up extracts natural antioxidants from agricultural waste and has successfully closed its pre-seed funding round with SICTIC business angels, Venture…

The longetivity start-up, based at Biopôle, is funded by Prima Materia, the investment firm founded by Spotify founder Daniel Ek and…

The Mutual Recognition Agreement (MRA) between Switzerland and the United States in the area of Good Manufacturing Practice for medicinal…

Medicxi, a leading European life sciences investment firm, announces its $400 million Medicxi IV fund. The new fund will continue…

After spending a year in the Pediatric Intensive Care Unit at CHUV, a 4-year-old boy did not need a heart…

Geneva-based Givaudan has expanded the Protein Hub at its flagship Zurich Innovation Centre in Kemptthal, to support the growth of dairy…

The fund offers up to CHF 90,000 a year, over three consecutive years, to promising life sciences ventures.    …

PeriVision is utilizing the power of artificial intelligence (AI), virtual reality (VR), and cloud computing to redefine eye testing and…

The HUG and the Institut Pasteur have announced an exceptional case of HIV remission. A promising discovery.   The patient…

The Swiss Central Union for the Blind (UCBA) awards projects for blind, partially sighted and deaf-blind people. Twenty-one projects were…

Magali Bischof, BioAlps’ Secretary General is interviewed by Benjamin Smadja during the 13 World Chambers congress organised by CCIG Geneva. Watch…

ten23 health® announces the launch of “quality control” service offerings in Switzerland for release and stability testing of clinical and…

After raising CHF 850 000 in January, and starting a clinical trial in Australia, the Swiss Medtech startup launches a…

On Thursday 1 June, the Swiss Health Valley Community was received by Hôpital de la Tour in Meyrin during a…

Medical technology companies are still grappling with the new rules on healthcare devices and diagnostics, two years after they came…

The Swiss-based biopharmaceutical company launches a new online portal to support people with cancer, with an initial focus on prostate…

BioAlps President, Prof. Antoine Geissbuhler, takes a new position. He is now at the helm of UNIGE Faculty of Medicine….

This subtype of cancer, which is particularly aggressive in children and frequent in adults, responds poorly to current standard treatments….

The Swiss government is investing CHF47 million in four national research programmes: gender medicine, biodiversity, new construction techniques and crop…

Adare Biome, a unit of Adare Pharma Solutions (CDMO), is a historic player in the development and manufacturing of postbiotic…

In 2016 FONGIT, in Geneva, and EPFL Innovation Park launched the Geneus program – the first innovation initiation program –…

Lausanne-based biopharmaceutical company AC Immune SA, announced that it has received Fast Track designation from the U.S. Food and Drug…

Over 150 innovation and healthcare players attended the presentations of the 12 finalist projects during the finale of the second…

The FIT, (Fondation pour l’Innovation Technologique) in canton of Vaud awarded 4 promising Swiss Health Valley projects. DNAQuraCy spun out…

The startup uses molecular signatures that can be used like bar codes to identify molecules, and developed a technology to…

For the first time, a multidisciplinary team from the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE)…

The Swiss Health Valley start-up develops a novel image guidance system for the non-invasive treatment of Ventricular Tachycardia through Proton…

Several Swiss Health Valley projects were rewarded during the finale of the >>venture>> Startup Competition on 26 June 2023, at…

Altis Labs is a Canadian computational imaging company accelerating clinical trials with artificial intelligence.   “We are thrilled to partner…

Le Temps, and its main partner Romande Energie, announced the Sustainable Start-Up 2023 Prize   Bloom Biorenewables, a Fribourg based…

Lunaphore Technologies SA, a Vaud-based (Switzerland) life sciences company developing technology to enable spatial biology in every laboratory, announced it…

Under the guidance of its Director General Nicolas Demartines, the CHUV was the first hospital in Switzerland to adopt the…

biped.ai, Gaia Technologies and Limula received a W. A. de Vigier Award, each endowed with CHF 100,000. Over 300 submitted…

Together with African and European partner universities, the University of Bern is developing is establishing two long-term research collaborations. These…

bNovate Technologies, a leader in rapid bacterial detection systems for water, has announced a CHF 12 million Series C funding…

The FIT (Fondation pour l’Innovation Technologique) gives a Tech Growth loans of CHF 400’000 to the EPFL spin-off, allowing her…

The EPFL spin-off, founded in 2010, wins the Swiss Medtech Award 2023 valued at CHF 75,000. Abionic specialises in providing…

Regen Lab, a Swiss commercial-stage medical technology company specializing in the research, development, registration, manufacturing and commercialization of proprietary tissue…

A messenger RNA vaccine developed by Moderna, which has recently been shown to be effective against certain cases of melanoma,…

Researchers from the University of Bern, Inselspital, University Hospital Bern, and the University of Connecticut have made a significant breakthrough…

German laboratory Merck invested CHF 250 million in Corsier-sur-Vevey (VD). The 15,700 m2 building will combine research and production of…

Selexis, an EFPL startup, was founded in 2005 before being acquired by KBI Biopharma Inc, a subsidiary of the Japanese…

The Valais-based pharmaceutical subcontractor will pay an initial €100 million, with subsequent milestone payments of up to a further €60…

The Swiss Biotech Report 2023 recently unveiled an impressive portrait of Switzerland’s thriving biotech sector. With record revenues of CHF…

Among the various pregnancy complications, one of the most serious and potentially life-threatening conditions is preeclampsia affecting 3 to 8%…

A UNIGE team has discovered how the influenza A virus hijacks the mechanism for importing iron into cells to invade…

After raising CHF 3.8 Million last month, the Fribourg-based startup won the third and final stage of the Venture Kick…

Artiria Medical, a Vaud-based neurovascular MedTech company, announces that its real-time deflectable guidewire has been granted the 510(k) clearance by…

Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL and CEA/CHUGA/UGA report in the journal Nature that they have re-established communication between the brain…

From a record number of over 300 submitted projects, the jury picked their Top 10. On 20 June 2023, up…

Fongit, the Fondation Genevoise pour l’Innovation Technologique, has awarded two Seed loans of 100,000 CHF to Fluosphera SA and Kylys…

Fribourg, Geneva, Jura, Valais and Vaud are aiming to establish a legal basis for the provision and operation of other…

New lead is purpose-designed to optimize the delivery of ONWARD ARC Therapy™   ONWARD Medical, a medical technology company working…

On 2 May 2023, BioAlps and Intuitive Surgical co-organised an  Investors et Innovators Connect event. Our association scouted projects in…

Dr Noémie Lang, oncologist at Geneva University Hospital (HUG), wins the prestigious Swiss Group for Clinical Cancer Research (SAKK) Trial…

On 11 May 2023, 31 early stage life sciences projects were presented to the public at the AGORA (Fondation ISREC)…

With CHF 45 million raised, the start-up NewBiologix, officially launched on 11 May 2023 at the Biopôle in Epalinges, has…

Novostia SA is a clinical stage company developing a breakthrough artificial heart valve.   Founded in April 2017, in Neuchâtel,…

Collaboration is key to foster innovation in the Swiss Health Valley   Founded in 2003, BioAlps empowers the Swiss Health…

The Swiss company has been able to recreate the unique diversity of glycan structures found in breast milk, nature’s perfect…

The two companies join forces to bring AI-based echocardiography solution, Ligence Heart, in Switzerland and North Africa (Morocco, Algeria, Tunisia…

SAK (St. Gallisch-Appenzellische Kraftwerke AG) has acquired a participation in Domo Health as part of a round of capital raising….

Within the framework of the Swiss Accelerator, Innosuisse supports 53 innovation projects by SMEs and startups and grants each of…

Limula SA receives CHF 2.5 million in non-dilutive funding to accelerate the industrialisation of a closed, automated, and modular solution…

machineMD, a Bern-based medtech company, was awarded the top prize at the prestigious Innovation World Cup® 2023, hosted during the…

The biomanufacturing company invests of up to CHF 25 million in Valais (Switzerland) for a new global R&D Center for…

Swiss Biotech Report 2023 shows sector weathers global disruption well and continues to play a leading role driving global healthcare…

Suspected of causing cancer, titanium dioxide, a white colouring agent, has been banned from food in Switzerland and Europe since…

George Coukos, full professor at the Faculty of Biology and Medicine of UNIL, director of the Department of Oncology UNIL-CHUV…

The fundraise, led by Revival Healthcare Capital, will be used to get a Food and Drug Administration (FDA) approval for…

A study led by the UNIGE, HES-SO Geneva, and EPFL revealed that music practice and active listening could prevent working…

Nagi Bioscience releases an end-to-end automated device to screen drugs, chemicals and others substances on micro-organisms.   Swiss EPFL spin-off…

Swiss entities can participate in most Horizon Europe calls. Funding is provided by the Swiss government as long as Switzerland…

The new centre will be dedicated to synthetic immunotherapy and immune engineering on the Biopôle site in Epalinges.   The…

The Executive Board of the Wyss Center for Bio and Neuroengineering, a non-profit research center, is pleased to announce the…

The new line will support customers with a range of drug product manufacturing needs for both clinical and commercial supply….

15 startups were selected among 300 projects. 5 of them are set to win CHF 100,000. The Award Ceremony is…

The creation of an Obesity Center at the CHUV enables the teams of Dr. Lucie Favre, head of the Obesity…

The EPFL spin-off is active in high-throughput RNA sequencing, used to examine gene expression and discover new biomarkers and drugs….

The Swiss startup plans to use the funding to strengthen its growing portfolio offering in spatial biology.     Lunaphore…

Viva VOsCE is a revolutionary project aiming at transforming medical education through harnessing the power of Virtual Reality (VR) technology….

Plair, Endotelix and Dr Beat Walpoth received funding from the Fongit Innovation Fund (FIF).   Plair SA: Growth loan of…

Senbiosys developed a smart ring and an application to give users inputs about their health and wellness. The EPFL spin-off…

16 projects have been selected for the 2023 programme   Tech4Eva is an EPFL Innovation Park and Groupe Mutuel initiative…

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and M Ventures, the strategic, corporate venture capital…

Medyria’s PyCath aims to be the only device on the market with pressure and blood flow velocity sensing for the…

SOPHiA GENETICS, a Lausanne-based cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with…

GeNeuro develops timelimab, an antibody that showed promising results in treating inflammatory symptoms for long COVID patients   GeNeuro, a…

The Jura branch of the Swiss Innovation Park Basel Area is home to 28 companies and institutions, including ten in…

The Lausanne-based biotech company has obtained global rights from a Novo Nordisk molecule and plans to take the compound forward…

Raphaël Conz is also BioAlps’ vice-president. For many years, he has worked to promote the attractiveness and the reputation of…

The largest independent sterilisation company in Europe invests to expand its plant in Domdidier, in the canton of Fribourg.  …

A Swiss Health Valley success story! Oculis goes public.   Oculis Holding AG (“Oculis”), based at EPFL Innovation Park in…

A swissmade neuromodulator to treat erectile dysfunction starts clinical trials in Australia   Comphya SA, developer of the first neuromodulator…

The US accelerator IndieBio New York which is part of SOSV, Swiss-based Mountain Labs, and EFI Lake Geneva Ventures participated…

Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore’s flagship COMET™ spatial biology platform as a service….

Leenaards Foundation announces three winners of the 2023 Science Prizes. CHF 1.5 million are awarded to support biomedical research in…

In financial trouble, the Geneva-based femtech company had to lay off its employees and reorganize its management   Obseva, in…

The Swiss MedTech company is developing next generation imaging technology, and closed a Pre-Series A investment round. This funding supports…

 The two companies are partnering to accelerate the process of personalized cancer drug profiling leveraging the potential of both company’s…

MindMaze, a global pioneer in the development of AI-driven digital neurotherapeutics, is proud to announce the US and EU launch…

CSS and EPFL announce the 2nd cohort of the Future of Health Program   The Future of Health Grant (FoHG)…

Biopôle-based SEED Biosciences teams up with Molecular Devices, LLC. The American leading provider of high-performance life science solutions is now…

Faced with a shortage of qualified personnel in the field of mathematics, computer science, natural sciences and technology (MINT) in…

The EPFL-based start-up accepted the offer of the Spanish company. The amount of the transaction has not been disclosed.  …

The Swiss start-up, specialised in AI assisted medicine, and the Swedish-British pharmaceutical company want to create multimodal approaches for cancer drug…

BioAlps recently collaborated with Labiotech.eu to detect the 13 biotech and healthtech companies in the Swiss Health Valley to watch…

Hôpital de La Tour in Geneva sells its premises to finance an ambitious innovation-oriented health campus   The owners of…

Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Target ALS Foundation (Target ALS) provide more than USD 500,000 in…

Carevix™, a novel atraumatic cervical stabilizer created by the Swiss startup ASPIVIX SA, received 510(k) clearance from the U.S. Food…

The initiative, which includes up to CHF 90,000 of support per year for up to three consecutive years, is designed…

A Health Valley partnership to revolutionize cancer therapies and to bring a personalised treatment for cancer patients   CSEM supports…

CALCISCON, AMSTERDAM UNIVERSITY MEDICAL CENTERS and ADMESY have signed a collaborative agreement for the development of a laboratory benchtop analyzer…

Xsensio Announces Know-How and Stock Purchase Agreement with Mayo Clinic   Xsensio, a Vaud-Based company that is developing the Lab-on-Skin©…

Comphya SA, developer of the first neuromodulator to treat erectile dysfunction (ED), announced the fundraising of CHF 850k in a…

According to a Deloitte study, investing in research is less and less interesting. The audit and consulting firm used figures…

The biopharmaceutical company employs 5,000 people in Valais, and also announced a 15% sales growth in 2022, representing a total…

The three partners secured a €1 million ($1.1 million) in Eurostars grant funding to develop a first of a king…

Listen to Magali Bischof, BioAlps Secretary General, on Beyond Biotech podcast speaking about the Swiss Health Valley and the role…

A breakthrough in the fight against cancer: researchers from EPFL, the Ludwig Institute of the CHUV, the SIB, and Roche…

The new Centre for Virtual Medicine at the HUG is a pioneer in the use of virtual reality for clinical…

The Swiss-based startup builds devices to automate processes in Life Science research and prepares a product rollout and expansion.  …

MachineMD, a spin-off of Inselspital Bern, and CSEM, are collaborating to diagnose brain diseases by analyzing eye movements with a…

Neurosoft Bioelectronics SA, a startup developing implantable brain-computer interfaces, announces that it has received ISO 13485:2016 Certification by TÜV SÜD…

The contract covers the delivery of a large volume of peptides over a five-year period from 2025-2029, and follows the…

machineMD (1st place), Pace Locator (2nd place) and Compact Motion (3rd place). The Innovation Award, worth a total of CHF…

MPC Therapeutics (MPC Tx), is a Swiss biotechnology company based in Geneva, focusing on metabolism and cellular rejuvenation.   The…

ten23 health®, a global contract development and manufacturing organization (CDMO) announces the change in branding of its in Visp, Switzerland…

The transaction with Novartis reinforces STALICLA’s position as the leading developer of precision medicines for neurodevelopmental disorders and heralds the…

mimiX biotherapeutics launches a funding round to accelerate clinical translation of FastSkin® MIMIX BIOTHERAPEUTICS LTD, a Swiss medical technology company…

Resistell provides information on which antibiotic should be used to treat the patient, and the concentration at which it should…

Funding will support iOnctura’s clinical program for IOA-289, a first-in-class autotaxin inhibitor for the treatment of pancreatic cancer   iOnctura…

The startup Biped created a harness equipped with 3D cameras that beeps when there is a risk of hitting an…

Tandem Diabetes Care, a global US-Based insulin delivery and diabetes technology company, announced an agreement to acquire AMF Medical SA,…

In 2021, private companies spent CHF 16.8 billion in Switzerland on in-house research and development (R&D) activities. This represents an…

The Scientist magazine announced its top 10 new products selected by a panel of independent judges. The Lausanne-based start-up Nanolive…

The 7th Debiopharm-La-Solution.ch-Inartis Challenge for the Quality of Life of Patient has rewarded with a prize of CHF 25’000 the…

How to attract and retain talented workers in the Biotech Industry? And how to train the new recruits efficiently? Lonza…

As of January 2023, Innosuisse is evolving. Grants will be distributed for international projects, and the financing of start-ups will…

You have an innovative project and are thinking of submitting an Innosuisse application? With its team of specialized advisors, Alliance…

Lack of resources and staff, aging population, an increase in chronic diseases: the challenges of the medical world are numerous…

200 patients are recruited and will be followed in 5 Swiss hospitals participating in the study. The first results are…

A new mission for BioAlps’ President   Professor at the Department of Radiology and Medical Informatics of the Faculty of…

The 12 000 m2 facility will be ready next spring in the Y-Parc in Yverdon-les-Bains. Leader in the production of custom-made…

Volumina Medical is an EPFL spin-off based in Biopôle Lausanne. The company develops a biogel that supports the repair of…

The Federal Council is to adapt national laws so that, in addition to medical devices with an EU certificate /…

The European Innovation Council Grant has been awarded to ONWARD and its research partners, including EPFL, IICT-BAS, CEA-Leti-Clinatec, and CEAList….

During the Swiss Innovation Forum on 23 November 2022 in Basel, Limula won the Inventor Award.   Two other companies…

This FLASH radiotherapy device will use very high-energy electrons (VHEE) to treat cancers that are resistant to conventional treatments, with…

The ceremony closed the BioAlps Networking Day on 24 November 2022 in Neuchâtel, in front of 250 key players of…

The dental products world leader employs 700 people in the canton.       Each fall, the Vaud International Business…

The Swiss company expects the sale proceeds to resolve its current over-indebtedness position ObsEva SA, a biopharmaceutical company based in…

Opna Bio, an Epalinges, Switzerland and San Francisco, CA-based clinical-stage biopharmaceutical company, raised $38M in Series A funding. The round…

The former astronaut has spent 16 years as Chairperson of the Board of Directors   Effective June 2023, Claude Nicollier…

The company validated its approach in Colorectal Cancer (CRC) screening, and provides new molecular insights and predictive algorithms for patient…

Neuria gets CHF 30 000 to develop its digital therapy hidden in video games to help fight nutrition disorders  …

PeriVision was awarded an Innosuisse research grant together with the University Hospital Bern and ARTORG Center for Biomedical Engineering Research…

A Human lean Diagnostic programme in the canton of precision watchmaking   The historical heritage of high precision and core…

Domo Health, a leader in digital health, announced the launch of its clinical study in collaboration with Roche Pharma Suisse…

The swiss company invests into an Israelian SaaS Platform able to collect data and to reduce clinical trial timelines and…

Jocelyne Bloch and Grégoire Courtine, two Swiss researchers, have identified a group of nerve cells unrelated to the locomotor system…

Dr. Sacha Pierre Sidjanski is in charge of External Relations at the Faculty of Life Sciences at EPFL. He explains…

  On 22 September 2022, Jonathan Dickinson, executive vice-president at Incyte, received the Swiss Health Valley Community in Morges.  …

Alpha Chitin will manufacture both Novochizol™ raw materials and Novochizol™-based intermediate products.   Alpha Chitin, a French biobased chemistry company…

The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDM™ health data analysis platform available with Microsoft Azure…

The company will receive CHF 100,000 in technical support from CSEM to develop a smart factory and a 100% autonomous…

Prof. Yogeshvar Kalia is Professor at the Faculty of Pharmaceutical Sciences at the University of Geneva (UNIGE) speaks about the…

Researchers at the University of Bern and University Hospital Bern have been able to comprehensively study the bacteria of the…

The HUG and the Unige have found a way to better detect the antibodies that cause thrombosis, which leads to…

Nyon-based MedAlliance, a start-up active in the field of vascular medical technology, has been acquired by the American multinational Cordis…

Incubated at Microcity Neuchâtel, Netsensing Technology is excited to announce that it has been selected as one of the Top12…

Why is Western Switzerland is a perfect place for lifesciences companies? Listen to Denis Cavin, Economic Development Officer at State of Geneva…

The Lausanne-based company Oculis SA, and European Biotech Acquisition Corp, announced a business combination agreement to create a Nasdaq-listed biopharmaceutical…

The two co-founders of SUN bioscience received an EPFL Alumni Award, a price that distinguishes researchers over the course of…

Collecte d’informations pour un projet de recherche HEIG-VD / Institut et Haute Ecole de Santé La Source – Conciliation vie privée vie professionnelle – TOUTES LES SOLUTIONS DE TOUS LES SECTEURS D’ACTIVITE SONT LES BIENVENUES

The 225,000 m2 site, located in the towns of Satigny and La Plaine, has a largely automated production capacity of…

The leader in medical virtual reality (VR) training tools, based in Geneva, provides immersive virtual reality solutions that allow the…

Gleamer and HealthCare Konnect (HCK) partner to expand access to AI-Based double check-in fractures, effusions, dislocations and bone lesions on…

Bioinformatics pioneer gives way to the next generation   Ron Appel pioneered the field of bioinformatics in Switzerland and supported…

ArcoScreen and DAAV both receive a Tech Seed loan of CHF 100’000 from the Foundation for Technological Innovation (FIT). ArcoScreen…

Researchers from the University of Bern and Inselspital and University Hospital Bern, in collaboration with Australian scientists, are developing a…

The EPFL spin-off, active in the field of bone regeneration, prepares its US market entry.   “With aging population, fractures…

The swiss🇨🇭 researchers have deciphered the precise functioning of a protective mechanism that could lead to a potential post-infection treatment…

ONWARD, Haya Therapeutics, Retinai and Engimmune Therapeutics are in the top 18 Biotech companies in Europe according to investors. Stuck…

Clinique La Prairie and Skyviews Life Science Ltd are among the new investors   Volumina Medical, a spin-off from the…

Biopôle SA announces a new partnership with Edmond de Rothschild Real Estate SICAV for the construction of three new buildings…

Fongit, the Fondation Genevoise pour l’Innovation Technologique, has just announced the latest beneficiaries of the Fongit Innovation Fund (FIF). iOnctura…

EPFL Innovation Park and CSS present the 2022 cohort   The Future of Health Grant programme to support innovation in…

After the successful closing of a US $22.2 million Series C equity financing, Nanolive announces the appointment of two extraordinary…

The Swiss companies wants to accelerate the adoption of liquid biopsies for cancer testing   Swiss techbio company Hedera Dx,…

The platform for artificial intelligence solutions applied to medical imaging, announces a €27 million round of financing. The goal: to…

The Up-LIFT study evaluating ARC-EX Therapy demonstrated the effectiveness of the device to improve extremity strength and function in people…

Discover some of the key highlights of the national organization for biological and biomedical data science in the SIB Profile 2022, our annual activity report. Together, our infrastructure solutions, expertise and interdisciplinary collaborations foster better science and healthcare, and give Switzerland a strong voice in global issues around life science data.

This Agreement supports the development of molecules targeting acute myeloid leukemia, multiple myeloma, human papillomavirus (HPV) associated tumors, and additional…

The strategic investment arm of Swiss biopharmaceutical company Debiopharm wants to reduce biotherapies’ development time and cost using AI (Artificial…

17 Western Switzerland Life Sciences startups in biotech, medtech and foodtech were selected   The TOP 100 Swiss Startup Award 2022…

A new state-of-the-art biologics centre   Novartis announced plans to invest around CHF 100 million in the development of next-generation…

A jewel for biopharmaceutical education and research   The Biofactory Competence Center (BCC) in Freiburg inaugurated its new gene therapy…

Two BioAlps experts nominated   Two Life Sciences experts, Dominique Truchot-Cardot and Alexandre Pauchard, are among the 100 personalities of…

T‍he MedTech startup is developing a medical device for the early diagnosis of neurological disorders including brain tumors via neuro-ophthalmic…

The injection of the hormone GnRH improved the cognitive functions of several Down syndrome patients   An Inserm team within…

A new USD 0.5 million grant brings up to USD 3.7 million the total amount The Michael J. Fox Foundation…

Sensawear wins a CHF 150,000 Venture Kick grant to develop its wearable tissue health monitor   Sensawear has developed the…

The Swiss start-up wants to develop an AI-SaaS to democratize the use and interpretation of ultrasound   SightIn Health’s Machine…

The DayOne Tech Accelerator in the Canton of Jura has just announced its winners. Three Medtech startups are starting a…

AC BioScience, a Biopôle-based clinical-stage biotech company pioneering the development of novel therapies in immuno-oncology and tumour vascular normalization, announces…

Ophthalmic devices and Geneva-based Alcon has reached an agreement to acquire North Carolina-based Aerie Pharmaceuticals for $770 million (743.1 million…

Under consideration since 2021, the details of the demerger of Sandoz, the generic drug arm of Swiss pharmaceutical giant Novartis,…

Vaud-based and EPFL spin-off startup TWIICE receives a CHF 100 000 seed loan from FIT   Every year, around 250,000…

Abionic’s test identifies in 5 minutes the earliest signs of sepsis 3 days before the standard of care. The technology…

The ObsEva laboratory is to engage in a vast restructuring process in the face of difficulties encountered with the FDA…

The Dexter® on-demand robotic surgery system created by the swiss company Distalmotion is now used by the Department for Women’s…

Debiopharms and UNIGE want to fight together against cancer and drug-resistant bacterial infections JULY 25, 2022   Debiopharm, a Swiss…

Nanodecoder, an EPFL spin-off, receives CHF 100 000 from FIT   The Fondation pour l’Innovation Technologique selection committee announced they…

Nestlé Health Science has signed a collaboration agreement with French company Enterome to target food allergies and chronic intestinal diseases…

Strategic collaboration to create therapies against digestive diseases   Perseo pharma, a preclinical stage biopharmaceutical company focused on breaking new…

The swiss and the Swedish companies partner for the development and commercialization of ZYNLONTA®, a drug for hematologic and solid…

The biotech company evaluates the effects of glycopeptides on solid tumors   Gnubiotics Sciences, a biotech company pioneering the discovery…

The Tech4Eva alumni and University Hospital Zurich (USZ) uses AI for faster and better breast cancer diagnostics     b-RayZ AG…

KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, have inaugurated an expanded, fully-integrated mammalian contract development…

The State of Vaud commits on giving CHF 2 million / year to the Fondation pour l’Innovation Technologique (FIT)  …

Lonza plans to construct a large-scale commercial drug product fill and finish facility in Stein (CH). CHF 500 million will…

To strengthen the development of the Canton and in particular the expertise of the CHUV and the University of Lausanne…

ClexBio, a Norway-based startup, is teaming up with CSEM to develop the world’s first machine to grow tissue-engineered human veins…

The Wyss Center for Bio and Neuroengineering, a non-profit organization dedicated to accelerating discoveries in neuroscience to improve patient lives,…

Geneva-based researcher Madiha Derouazi is co-winner of the European Inventor Award. With the French immunologist Elodie Belnoue, she is rewarded…

The company plans to establish a new 5,000 m2 manufacturing facility in Visp.    In October 2021, ten23 health acquired a…

EPFL Innovation Park is turning 30 this year and wants to expand. A new site, called Ecotope,  will bring together…

The Swiss Federal Agency for Innovation Promotion (Innosuisse) is supporting the “PROFICIENCY” project, in which the Geneva-based startup ORamaVR S.A….

By combining its novel bioreactor with state-of-the-art sensors and predictive data intelligence, Limula will add significant value to its cell & gene therapy manufacturing solution, paving the way for in-process control for the production of highly personalised cancer treatments.

Bernese start-up AlveoliX was awarded the Swiss Medtech Award, and prize money totaling CHF 75,000.   AlveoliX, founded in 2019,…

The University Hospital of Vaud (CHUV) in Lausanne is expanding its strategy to better fight all forms of cancer. The…

On 9 June 2022, during a BioAlps’ 4à6 event, the Heath Valley Community had the opportunity to visit OM Pharma…

Cytiva opens its new 7,400 m2 production facility in Grens, Switzerland, on 31 May 2022.   The site will manufacture…

What is your favorite swiss startup?   Every year the TOP 100 Swiss Startup Award showcases the 100 most innovative…

A Digital Health specialist to promote the Swiss Health Valley and the number one and most diversified Life Sciences Cluster…

Alithea Genomics, a Lausanne-based fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced the closing of…

The CEO and Director of AC Immune SA was recognized for her work to find treatments for Alzheimer’s disease  …

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat retinal diseases,…

This new centre, dedicated to sport and performance, is the result of collaboration between the City of Sion and The…

On 17 May 2022, Hansjörg Wyss received the Gallatin Award from the Swiss American Chamber of Commerce for his great…

This is the first time the ARCIM is used on a human patient. This implantable pulse generator (IPG) stimulates the…

HemostOD has developed a solution for ex vivo on-demand production of blood platelets. The company just received a CHF 100…